• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在台湾的一例输入性人感染甲型 H7N9 禽流感病毒病例的病毒学、血清学和抗病毒研究。

Virological, serological, and antiviral studies in an imported human case of avian influenza A(H7N9) virus in Taiwan.

机构信息

Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University College of Medicine.

出版信息

Clin Infect Dis. 2014 Jan;58(2):242-6. doi: 10.1093/cid/cit638. Epub 2013 Sep 27.

DOI:10.1093/cid/cit638
PMID:24076969
Abstract

We describe the clinical course and virological characteristics of the first H7N9 influenza case in a Taiwanese patient; this patient had detectable viruses in the airway for 2 weeks, during which time an oseltamivir resistance-associated R292K mutation rapidly emerged. Anti-H7N9 antibody was detected 21 days after onset of symptoms, when H7N9 viral load declined significantly.

摘要

我们描述了首例台湾地区人感染 H7N9 流感病例的临床经过和病毒学特征;该患者在呼吸道中可检出病毒达 2 周,在此期间,奥司他韦耐药相关的 R292K 突变迅速出现。在症状出现后 21 天检测到抗 H7N9 抗体,此时 H7N9 病毒载量显著下降。

相似文献

1
Virological, serological, and antiviral studies in an imported human case of avian influenza A(H7N9) virus in Taiwan.在台湾的一例输入性人感染甲型 H7N9 禽流感病毒病例的病毒学、血清学和抗病毒研究。
Clin Infect Dis. 2014 Jan;58(2):242-6. doi: 10.1093/cid/cit638. Epub 2013 Sep 27.
2
Pyrosequencing reveals an oseltamivir-resistant marker in the quasispecies of avian influenza A (H7N9) virus.焦磷酸测序揭示甲型流感病毒(H7N9)准种中奥司他韦耐药标志物。
J Microbiol Immunol Infect. 2015 Aug;48(4):465-9. doi: 10.1016/j.jmii.2013.09.010. Epub 2013 Dec 30.
3
Host immunological response and factors associated with clinical outcome in patients with the novel influenza A H7N9 infection.新型甲型 H7N9 流感感染患者的宿主免疫反应和与临床结果相关的因素。
Clin Microbiol Infect. 2014 Aug;20(8):O493-500. doi: 10.1111/1469-0691.12505. Epub 2014 Jan 21.
4
A case of human infection with avian Influenza A/H7N9 virus in Beijing: virological and serological analysis.北京一例人感染甲型H7N9禽流感病毒病例:病毒学和血清学分析
J Infect Dev Ctries. 2015 Mar 15;9(3):317-20. doi: 10.3855/jidc.5875.
5
Characterization of viral genomic mutations in novel influenza A (H7N9)-infected patients: the association between oseltamivir-resistant variants and viral shedding duration.新型甲型H7N9流感感染患者病毒基因组突变特征:耐奥司他韦变异体与病毒排毒持续时间的关联
Virus Genes. 2019 Oct;55(5):592-599. doi: 10.1007/s11262-019-01678-8. Epub 2019 Jul 13.
6
Neuraminidase Mutations Conferring Resistance to Oseltamivir in Influenza A(H7N9) Viruses.甲型H7N9流感病毒中赋予对奥司他韦耐药性的神经氨酸酶突变
J Virol. 2015 May;89(10):5419-26. doi: 10.1128/JVI.03513-14. Epub 2015 Mar 4.
7
Characterization of drug-resistant influenza A(H7N9) variants isolated from an oseltamivir-treated patient in Taiwan.从台湾一名接受奥司他韦治疗的患者中分离出的耐药甲型H7N9流感病毒变异株的特征分析
J Infect Dis. 2015 Jan 15;211(2):249-57. doi: 10.1093/infdis/jiu447. Epub 2014 Aug 14.
8
Inhibition of novel reassortant avian influenza H7N9 virus infection in vitro with three antiviral drugs, oseltamivir, peramivir and favipiravir.用三种抗病毒药物(奥司他韦、帕拉米韦和法匹拉韦)在体外抑制新型重配禽流感H7N9病毒感染
Antivir Chem Chemother. 2014 Dec 16;23(6):237-40. doi: 10.3851/IMP2672.
9
Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance.新型甲型 H7N9 流感病毒导致的人类疾病不良临床结局与病毒持续排出和抗病毒耐药性的出现之间的关联。
Lancet. 2013 Jun 29;381(9885):2273-9. doi: 10.1016/S0140-6736(13)61125-3. Epub 2013 May 29.
10
Characterization of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Taiwan in 2009-2011.2009-2011 年台湾地区奥司他韦耐药甲型 H1N1pdm09 流感病毒的特征。
J Med Virol. 2013 Mar;85(3):379-87. doi: 10.1002/jmv.23482. Epub 2012 Dec 21.

引用本文的文献

1
Novel Avian Influenza A Virus Infections of Humans.新型禽流感病毒感染人类。
Infect Dis Clin North Am. 2019 Dec;33(4):907-932. doi: 10.1016/j.idc.2019.07.003.
2
Virus-induced pathogenesis, vaccine development, and diagnosis of novel H7N9 avian influenza A virus in humans: a systemic literature review.人感染新型H7N9禽流感病毒的病毒诱导发病机制、疫苗研发及诊断:一项系统性文献综述
J Int Med Res. 2020 Jan;48(1):300060519845488. doi: 10.1177/0300060519845488. Epub 2019 May 8.
3
H7 virus-like particles assembled by hemagglutinin containing H3N2 transmembrane domain and M1 induce broad homologous and heterologous protection in mice.
血凝素含 H3N2 跨膜域和 M1 的 H7 病毒样颗粒在小鼠中诱导广泛的同源和异源保护。
Vaccine. 2018 Aug 9;36(33):5030-5036. doi: 10.1016/j.vaccine.2018.07.004. Epub 2018 Jul 7.
4
Sudden emergence of human infections with H7N9 avian influenza A virus in Hubei province, central China.中国中部湖北省发生人感染 H7N9 禽流感病毒的突发疫情。
Sci Rep. 2018 Feb 6;8(1):2486. doi: 10.1038/s41598-018-20988-9.
5
Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.灭活H7流感病毒疫苗尽管仅诱导产生低水平的中和抗体,但仍可保护小鼠。
J Virol. 2017 Sep 27;91(20). doi: 10.1128/JVI.01202-17. Print 2017 Oct 15.
6
Predictors for fatal human infections with avian H7N9 influenza, evidence from four epidemic waves in Jiangsu Province, Eastern China, 2013-2016.预测 2013-2016 年中国东部江苏省四起人感染 H7N9 禽流感疫情的致死因素。
Influenza Other Respir Viruses. 2017 Sep;11(5):418-424. doi: 10.1111/irv.12461. Epub 2017 Jul 26.
7
Genomic Signatures for Avian H7N9 Viruses Adapting to Humans.适应人类的禽H7N9病毒的基因组特征
PLoS One. 2016 Feb 4;11(2):e0148432. doi: 10.1371/journal.pone.0148432. eCollection 2016.
8
Recombinant Hemagglutinin and Virus-Like Particle Vaccines for H7N9 Influenza Virus.用于H7N9流感病毒的重组血凝素和病毒样颗粒疫苗
J Vaccines Vaccin. 2015 Jun;6(3). doi: 10.4172/2157-7560.1000287. Epub 2015 Jun 30.
9
Challenges and Strategies of Laboratory Diagnosis for Newly Emerging Influenza Viruses in Taiwan: A Decade after SARS.台湾新出现流感病毒的实验室诊断挑战与策略:SARS 十年后
Biomed Res Int. 2015;2015:805306. doi: 10.1155/2015/805306. Epub 2015 Jul 28.
10
Recombinant H7 hemagglutinin forms subviral particles that protect mice and ferrets from challenge with H7N9 influenza virus.重组H7血凝素形成亚病毒颗粒,可保护小鼠和雪貂免受H7N9流感病毒的攻击。
Vaccine. 2015 Sep 11;33(38):4975-82. doi: 10.1016/j.vaccine.2015.07.026. Epub 2015 Jul 21.